Paradigm Capital Management Inc. NY raised its position in Helen of Troy Limited (NASDAQ:HELE – Free Report) by 64.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 927,100 shares of the company’s stock after purchasing an additional 362,900 shares during the quarter. Paradigm Capital Management Inc. NY’s holdings in Helen of Troy were worth $13,369,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. iSAM Funds UK Ltd acquired a new stake in shares of Helen of Troy during the 3rd quarter worth approximately $27,000. Allworth Financial LP lifted its holdings in Helen of Troy by 922.7% in the fourth quarter. Allworth Financial LP now owns 1,350 shares of the company’s stock valued at $29,000 after acquiring an additional 1,218 shares during the last quarter. Farther Finance Advisors LLC grew its position in Helen of Troy by 5,529.2% in the fourth quarter. Farther Finance Advisors LLC now owns 1,351 shares of the company’s stock worth $29,000 after acquiring an additional 1,327 shares during the period. Larson Financial Group LLC grew its position in Helen of Troy by 1,323.2% in the third quarter. Larson Financial Group LLC now owns 1,352 shares of the company’s stock worth $34,000 after acquiring an additional 1,257 shares during the period. Finally, Tower Research Capital LLC TRC increased its stake in Helen of Troy by 216.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,998 shares of the company’s stock worth $57,000 after acquiring an additional 1,366 shares during the last quarter.
Helen of Troy Stock Up 6.1%
Shares of NASDAQ HELE opened at $28.47 on Friday. The firm has a market cap of $663.12 million, a price-to-earnings ratio of -1.58 and a beta of 1.31. The company has a quick ratio of 0.81, a current ratio of 1.78 and a debt-to-equity ratio of 0.82. Helen of Troy Limited has a 52-week low of $13.85 and a 52-week high of $30.68. The business’s 50 day moving average is $27.05 and its two-hundred day moving average is $21.45.
Analyst Ratings Changes
HELE has been the topic of a number of research analyst reports. Weiss Ratings downgraded Helen of Troy from a “sell (d)” rating to a “sell (d-)” rating in a research report on Tuesday. Canaccord Genuity Group increased their price target on Helen of Troy from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Thursday, July 9th. Wall Street Zen raised Helen of Troy from a “hold” rating to a “strong-buy” rating in a research report on Sunday, July 12th. Zacks Research lowered shares of Helen of Troy from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Finally, UBS Group upped their target price on shares of Helen of Troy from $25.00 to $28.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Helen of Troy has an average rating of “Hold” and an average target price of $26.50.
Read Our Latest Report on Helen of Troy
Key Stories Impacting Helen of Troy
Here are the key news stories impacting Helen of Troy this week:
- Positive Sentiment: A recent valuation-focused article highlighted Helen of Troy as potentially still undervalued even after a sharp rally, suggesting some investors may see room for further upside. Is It Too Late to Buy Helen Of Troy Ltd (HELE) After 3.3% Rally? GF Value Says Undervalued
- Neutral Sentiment: Several entertainment-related articles mention “Helen of Troy” in connection with Lupita Nyong’o and Christopher Nolan’s The Odyssey, but these are unrelated to the company and should not affect fundamentals. Teacher schools white people who have a problem with Lupita Nyong’o as Helen of Troy
- Neutral Sentiment: Additional media references to “Helen of Troy” in entertainment coverage are likewise not business updates for the consumer-products company. I’m a Black Greek Woman. What Lupita Nyong’o’s Casting as Helen of Troy in ‘The Odyssey’ Meant to Me
- Negative Sentiment: Multiple law firms announced or reminded investors about a class-action lawsuit against Helen of Troy Limited, alleging securities-law violations and investor harm for purchases made between April 24, 2024 and October 8, 2025. This legal overhang can weigh on sentiment as investors assess potential costs and reputational damage. Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm
- Negative Sentiment: Another investor alert repeated the same class-action claims and deadline reminders, reinforcing concerns about litigation risk for HELE. HELE Investors are Reminded of the Pending Lead Plaintiff Deadline on August 3, 2026; Contact Robbins LLP for Information About Recovering Your Losses
- Negative Sentiment: A third legal notice from Pomerantz LLP also flagged the lawsuit and upcoming deadlines, adding to the steady stream of negative headline risk around the stock. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Helen of Troy Limited of Class Action Lawsuit and Upcoming Deadlines – HELE
Helen of Troy Profile
Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.
The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.
Further Reading
- Five stocks we like better than Helen of Troy
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding HELE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Helen of Troy Limited (NASDAQ:HELE – Free Report).
Receive News & Ratings for Helen of Troy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helen of Troy and related companies with MarketBeat.com's FREE daily email newsletter.
